Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antitumor granuloma formation by CD4+ T cells in a patient with rapidly progressive melanoma experiencing spiking fevers, neuropathy, and other immune-related toxicity after treatment with ipilimumab.

× No keyword cloud information.

23 in total

1. The significance of sarcoid-like lesions in association with malignant neoplasms.

Authors: H B GREGORIE; H B OTHERSEN; M P MOORE
Journal: Am J Surg Date: 1962-10 Impact factor: 2.565

2. Histopathology of tumour associated sarcoid-like stromal reaction in breast cancer. An analysis of 5 cases with immunohistochemical investigations.

Authors: R Bässler; F Birke
Journal: Virchows Arch A Pathol Anat Histopathol Date: 1988

3. Surgical results of lung cancer with sarcoid reaction in regional lymph nodes.

Authors: Yoshito Tomimaru; Masahiko Higashiyama; Jiro Okami; Kazuyuki Oda; Koji Takami; Ken Kodama; Yoshitane Tsukamoto
Journal: Jpn J Clin Oncol Date: 2007-02-01 Impact factor: 3.019

Review 4. Management of immune-related adverse events and kinetics of response with ipilimumab.

Authors: Jeffrey S Weber; Katharina C Kähler; Axel Hauschild
Journal: J Clin Oncol Date: 2012-05-21 Impact factor: 44.544

5. Sarcoid reactions in primary pulmonary carcinoma: report of seven cases.

Authors: M Kamiyoshihara; T Hirai; O Kawashima; S Ishikawa; Y Morishita
Journal: Oncol Rep Date: 1998 Jan-Feb Impact factor: 3.906

Review 6. CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.

Authors: Jianda Yuan; Brian Ginsberg; David Page; Yanyun Li; Teresa Rasalan; Humilidad F Gallardo; Yinyan Xu; Sylvia Adams; Nina Bhardwaj; Klaus Busam; Lloyd J Old; James P Allison; Achim Jungbluth; Jedd D Wolchok
Journal: Cancer Immunol Immunother Date: 2011-04-05 Impact factor: 6.968

Review 7. Sarcoid reactions in malignant tumours.

Authors: H Brincker
Journal: Cancer Treat Rev Date: 1986-09 Impact factor: 12.111

8. Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma.

Authors: Jeffrey S Weber; Reinhard Dummer; Veerle de Pril; Celeste Lebbé; F Stephen Hodi
Journal: Cancer Date: 2013-02-07 Impact factor: 6.860

Review 9. Granuloma formation, implications for the pathogenesis of vasculitis.

Authors: Michael C Sneller
Journal: Cleve Clin J Med Date: 2002 Impact factor: 2.321

10. The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells.

Authors: Hidetoshi Sumimoto; Fumie Imabayashi; Tomoko Iwata; Yutaka Kawakami
Journal: J Exp Med Date: 2006-06-26 Impact factor: 14.307

4 in total

Review 1. Proposed diagnostic and treatment paradigm for high-grade neurological complications of immune checkpoint inhibitors.

Authors: Dustin Anderson; Grayson Beecher; Nabeela Nathoo; Michael Smylie; Jennifer A McCombe; John Walker; Rajive Jassal
Journal: Neurooncol Pract Date: 2018-10-04

Antitumor granuloma formation by CD4+ T cells in a patient with rapidly progressive melanoma experiencing spiking fevers, neuropathy, and other immune-related toxicity after treatment with ipilimumab.